soluble receptor activator of nuclear factor κb ligandosteoprotegerin ratio is increased in systemic lupus erythematosus patients可溶性受体激活核因子κb ligandosteoprotegerin系统性红斑狼疮患者的比例增加.pdfVIP

soluble receptor activator of nuclear factor κb ligandosteoprotegerin ratio is increased in systemic lupus erythematosus patients可溶性受体激活核因子κb ligandosteoprotegerin系统性红斑狼疮患者的比例增加.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
soluble receptor activator of nuclear factor κb ligandosteoprotegerin ratio is increased in systemic lupus erythematosus patients可溶性受体激活核因子κb ligandosteoprotegerin系统性红斑狼疮患者的比例增加

Carmona-Fernandes et al. Arthritis Research Therapy 2011, 13:R175 /content/13/5/R175 RESEARCH ARTICLE Open Access Soluble receptor activator of nuclear factor B ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients 1† 1,2† 1 1,3 Diana Carmona-Fernandes , Maria José Santos , Inês Pedro Perpétuo , João Eurico Fonseca and Helena Canhão1,3* Abstract Introduction: Systemic lupus erythematosus (SLE) patients have lower bone mineral density and increased fracture risk when compared with healthy individuals, due to distinct factors and mechanisms. Bone remodeling is a tightly orchestrated process dependent on several factors, including the balance between receptor activator of nuclear factor B ligand (RANKL) and osteoprotegerin (OPG). Our aim was to assess serum OPG and soluble RANKL (sRANKL) levels as well as sRANKL/OPG ratio in female SLE patients and compare it with female controls. Methods: We have evaluated 103 SLE patients and 114 healthy controls, all Caucasian females. All participants underwent a clinical and laboratory evaluation. sRANKL and OPG were quantified in serum by ELISA based methods. sRANKL, OPG and sRANKL/OPG ratio levels were compared between SLE patients and age, sex and race matched healthy controls. For SLE patients, a multivariate analysis was performed, to find the possible predictors of the changes in sRANKL, OPG and sRANKL/OPG ratio levels. Results: Although sRANKL levels did not differ between the two groups, serum OPG was lower in SLE patients (P 0.001). This led to an increased sRANKL/OPG ratio (P = 0.010) in the patients’ group. The multivariate analysis was performed considering age and other clinical and laboratorial

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档